Doping ban for Maria Sharapova reduced

The Court of Arbitration for Sport (CAS), has reduced the two-year doping ban by nine months, for former world No.1 tennis player Maria Sharapova.

It was found that “Ms Sharapova committed an anti-doping rule violation and that while it was with ‘no significant fault’, she bore some degree of fault, for which a sanction of fifteen months is appropriate,” the Switzerland-based arbitration panel said in a statement.

The five-time grand slam winner Sharapova tested positive for the banned drug meldonium, during January’s Australian Open.


Her ban took effect on January 26, 2016.

The Russian star, who has racked up 35 WTA titles and more than $36 Million in career earnings, has maintained she was unaware the drug had been added to the banned list.